As of 2026-09-17, the EV/EBITDA ratio of Guardant Health Inc (GH) is -53.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GH's latest enterprise value is 23,641.22 mil USD. GH's TTM EBITDA according to its financial statements is -444.17 mil USD. Dividing these 2 quantities gives us the above GH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 10.5x | 9.6x |
| Forward P/E multiples | 8.1x - 11.4x | 9.3x |
| Fair Price | (30.79) - (38.49) | (35.13) |
| Upside | -117.6% - -122.0% | -120.1% |
| Date | EV/EBITDA |
| 2026-09-17 | -54.78 |
| 2026-09-16 | -53.23 |
| 2026-09-15 | -53.45 |
| 2026-09-14 | -51.12 |
| 2026-09-11 | -48.00 |
| 2026-09-10 | -48.49 |
| 2026-09-09 | -49.61 |
| 2026-09-08 | -49.07 |
| 2026-09-04 | -49.20 |
| 2026-09-03 | -49.09 |
| 2026-09-02 | -49.69 |
| 2026-09-01 | -50.09 |
| 2026-08-31 | -48.49 |
| 2026-08-28 | -49.23 |
| 2026-08-27 | -51.32 |
| 2026-08-26 | -52.04 |
| 2026-08-25 | -50.25 |
| 2026-08-24 | -49.73 |
| 2026-08-21 | -51.97 |
| 2026-08-20 | -51.13 |
| 2026-08-19 | -49.77 |
| 2026-08-18 | -48.81 |
| 2026-08-17 | -49.28 |
| 2026-08-14 | -47.94 |
| 2026-08-13 | -48.64 |
| 2026-08-12 | -50.30 |
| 2026-08-11 | -50.30 |
| 2026-08-10 | -50.93 |
| 2026-08-07 | -51.31 |
| 2026-08-06 | -48.06 |
| 2026-08-05 | -49.73 |
| 2026-08-04 | -48.72 |
| 2026-08-03 | -48.43 |
| 2026-07-31 | -49.37 |
| 2026-07-30 | -46.49 |
| 2026-07-29 | -44.02 |
| 2026-07-28 | -43.89 |
| 2026-07-27 | -44.44 |
| 2026-07-24 | -45.00 |
| 2026-07-23 | -45.85 |
| 2026-07-22 | -46.02 |
| 2026-07-21 | -46.48 |
| 2026-07-20 | -45.22 |
| 2026-07-17 | -47.54 |
| 2026-07-16 | -47.29 |
| 2026-07-15 | -49.66 |
| 2026-07-14 | -48.81 |
| 2026-07-13 | -48.30 |
| 2026-07-10 | -48.79 |
| 2026-07-09 | -50.00 |